Serums & Essences · 19/06/2026
At-home microneedling serum delivery: the channel-opening technology that makes topical actives work harder
The most potent topical active is limited by how much of it the skin barrier allows through. Channel-opening microneedle technology changes this relationship — with results that approach clinical treatments at home.
The skin barrier as a delivery challenge for skincare actives
The stratum corneum is one of nature's most effective selective barriers — keeping water in and potentially harmful substances out. Its selectivity is also the fundamental challenge of topical skincare delivery: the same properties that protect the skin from environmental entry apply equally to actives in skincare formulas. The passive diffusion rate through intact skin for any molecule depends on its size (smaller penetrates more easily), lipid solubility (lipophilic molecules integrate with the barrier lipids), and concentration gradient. Most topical actives — even well-formulated ones at appropriate concentrations — deliver only a fraction of their applied dose to the target cells in the epidermis and dermis where they need to be active.
What microneedle delivery systems do differently
Microneedle delivery systems create physical microchannels in the stratum corneum that bypass the passive diffusion limitation. Clinical microneedling (dermaroller, dermapen) creates controlled depths of channel that allow direct delivery of actives to the dermis — bypassing the stratum corneum limitation entirely for molecules that cannot otherwise penetrate. At-home microneedle technology adapted for safe consumer use creates much shallower channels — in the range of 0.1 to 0.5mm — that penetrate the stratum corneum without reaching the living dermis, dramatically improving the penetration of water-soluble actives that would otherwise be limited by the stratum corneum's resistance to aqueous penetration.
VT Reedle Shot 1300: 1,300 soluble microneedles per pump
The VT Cosmetics Reedle Shot technology delivers 1,300 soluble microneedles per pump dispense — structures that dissolve on contact with skin, forming transient microchannels in the stratum corneum as they dissolve. The microneedles are loaded with actives (PDRN, hyaluronic acid, niacinamide in various formulas) that are simultaneously delivered directly into the skin as the needle structure dissolves. This technology achieves transdermal delivery efficiency dramatically higher than conventional serum application — PDRN delivered via soluble microneedle reaches the lower epidermis at concentrations equivalent to what injection would provide at the same applied dose, a significant improvement over the conventional delivery limitation.
The microneedle mask for intensive area treatment
A microneedle sheet mask applies the same channel-opening technology across the full face simultaneously — 1,300 microneedles per cm² of mask surface creating a comprehensive network of transient delivery channels across the entire facial area rather than the sequential application of a pump serum. This format is particularly effective for intensive treatment sessions because the occlusive mask format maintains the microchannel open while the serum continuously delivers actives through them during the 15-to-20-minute wear period. The combination of physical channel creation and extended serum contact through the occlusion represents the highest-efficiency topical delivery system available for home use — with efficacy results in studies that approach fractional laser post-treatment delivery without the clinical environment requirement.
Safety considerations for at-home microneedle products
Soluble at-home microneedle products differ importantly from reusable physical microneedling devices (dermarollers) in their safety profile. Each dissolve-on-contact microneedle is sterile at the point of use and creates a shallower channel than physical needles, significantly reducing infection risk and the skin trauma associated with repeated mechanical microneedle contact. Physical dermarollers, if used incorrectly or without adequate sterilisation, can transfer bacteria and create deeper skin trauma than beneficial. The soluble microneedle technology represents a clinically appropriate consumer adaptation of the delivery mechanism without the safety concerns of physical devices. As with any active delivery system, damaged or compromised skin should not be treated — active acne, open wounds or active eczema are contraindications for any microneedle application.
